share_log

康諾亞-B:自願性公告 司普奇拜單抗治療成人中重度特應性皮炎的藥品上市許可申請獲國家藥品監督管理局受理

KEYMED BIO-B: VOLUNTARY ANNOUNCEMENT NEW DRUG APPLICATION OF STAPOKIBART FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS IN ADULTS ACCEPTED BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION

香港交易所 ·  Dec 6, 2023 23:21
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more